Sartorius | SRT3 - Assets

Stock Price
204.90
Daily Change
-8.60 -4.03%
Monthly
-14.20%
Yearly
-10.91%
Q2 Forecast
199.57

Sartorius reported EUR9.87B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Akebia Therapeutics USD 362.52M 14.04M Mar/2026
Alaunos Therapeutics USD 1.88M 1.08M Mar/2026
Avita Medical AUD 56.39M 1.74M Dec/2025
Dianthus Therapeutics USD 1.25B 715.96M Mar/2026
Ionis Pharmaceuticals USD 3.45B 74M Mar/2026
IQVIA Holdings USD 29.68B 269M Mar/2026
Moderna USD 11.49B 850M Mar/2026
Organon & Co USD 13B 129M Mar/2026
Revvity USD 12B 171.82M Mar/2026
Sartorius EUR 9.87B 154.9M Mar/2026
Tectonic Therapeutic USD 246.58M 14.46M Mar/2026
Viatris USD 36.83B 358.5M Mar/2026
Xeris Pharmaceuticals USD 392.01M 8.49M Mar/2026